Short Interest in Celularity Inc. (NASDAQ:CELUW) Drops By 55.9%

Celularity Inc. (NASDAQ:CELUW) was the recipient of a significant decrease in short interest in the month of May. As of May 29th, there was short interest totaling 10,742 shares, a decrease of 55.9% from the May 14th total of 24,342 shares. Based on an average daily volume of 14,702 shares, the short-interest ratio is presently 0.7 days.

Celularity Price Performance

Shares of NASDAQ CELUW traded down $0.00 during trading on Friday, hitting $0.00. 30,810 shares of the company traded hands, compared to its average volume of 19,834. The business’s fifty day moving average is $0.01 and its 200 day moving average is $0.01. Celularity has a fifty-two week low of $0.00 and a fifty-two week high of $0.06.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.